$35.27 $0.10 (0.3%)

03:38 PM EDT on 06/19/19

Nektar Therapeutics (NASDAQ:NKTR)

CAPS Rating: 4 out of 5

A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines.

Current Price $35.27 Mkt Cap $5.9B
Open $35.25 P/E Ratio 0.00
Prev. Close $35.17 Div. (Yield) $0.00 (0.0%)
Daily Range $35.00 - $35.81 Volume 194,252
52-Wk Range $30.05 - $47.10 Avg. Daily Vol. 33

Caps

How do you think NASDAQ:NKTR will perform against the market?

Add Stock to CAPS Watchlist

All Players

282 Outperform
36 Underperform
 

All-Star Players

63 Outperform
8 Underperform
 

Wall Street

10 Outperform
1 Underperform
 

Top NASDAQ:NKTR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFEBCapital (92.28)
Submitted April 26, 2017

Mgmt is seeking a commercialization partner for its chronic back pain drug following late-stage success. The drug targets mu-opioid receptors, but it's more selective, and passes the blood brain barrier less easily, so its less prone to abuse. I… More

honcharella (45.68)
Submitted March 14, 2007

This company just can't make a move upward. One of many with this type of technology and also one of many that just fails to produce results in the form of profits. Maybe one day... Just not today.

NASDAQ:NKTR VS S&P 500 (SPY)

Fools bullish on NASDAQ:NKTR are also bullish on:

Fools bearish on NASDAQ:NKTR are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about NKTR.

Recs

0
Member Avatar FVelociraptor (99.89) Submitted: 2/15/2019 9:29:21 PM : Outperform Start Price: $42.10 NASDAQ:NKTR Score: -22.27

http://velociraptor.cc

Recs

0
Member Avatar TMFBigFrog (95.13) Submitted: 12/26/2018 8:40:05 AM : Outperform Start Price: $30.77 NASDAQ:NKTR Score: -9.62

Reasonable pipeline despite near term uncertainty.

Recs

0
Member Avatar healthcarevalue (86.02) Submitted: 11/26/2018 5:37:33 PM : Outperform Start Price: $38.63 NASDAQ:NKTR Score: -18.78

Return on invested capital of over 64 in twelve trailing months. Price earnings ratio of 9 is pretty low and reasonable price. Debt equity ratio of 0.14 from latest quarter shows financial health is good. Market capitalization of 6.749 billion, combined with the high return on invested capital and low debt and low price earnings ratio, shows a healthy potential for acquisition, perhaps by another biotechnology firm, in order to expand their offerings and research.

Leaderboard

Find the members with the highest scoring picks in NKTR.

Score Leader

tkaskmaster

tkaskmaster (69.38) Score: +749.48

The Score Leader is the player with the highest score across all their picks in NKTR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
tkaskmaster 69.38 6/23/2008 Outperform 1Y $3.60 +879.72% +130.24% +749.48 0 Comment
bone777 < 20 7/10/2008 Outperform 3Y $3.60 +879.72% +143.76% +735.96 0 Comment
TheBotttomFeeder 40.13 9/30/2008 Outperform NS $3.65 +866.30% +164.45% +701.85 3 Comments
Mango777 79.68 7/18/2008 Outperform 5Y $4.01 +779.55% +139.63% +639.92 0 Comment
myfirstfund < 20 5/19/2008 Outperform 1Y $4.57 +671.77% +112.47% +559.30 0 Comment
b3agle 32.65 5/19/2008 Outperform 5Y $4.58 +670.09% +111.28% +558.81 1 Comment
GreedsGood04 < 20 6/3/2008 Outperform 1Y $4.58 +670.09% +118.27% +551.82 0 Comment
catjtthomas < 20 4/24/2008 Outperform NS $4.60 +666.74% +121.85% +544.89 0 Comment
MikeMcCroskey < 20 7/23/2008 Outperform 5Y $4.63 +661.77% +136.34% +525.43 0 Comment
Randomstocks 76.02 5/9/2008 Outperform 5Y $4.77 +639.41% +118.91% +520.50 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCowenandCo 76.19 9/12/2013 Outperform NS $13.57 +159.91% +73.14% +86.77 0 Comment
TrackLazardCapit 54.11 1/15/2013 Outperform NS $8.96 +293.64% +100.42% +193.22 0 Comment
TrackMKMPartners 87.06 8/19/2011 Outperform NS $5.15 +584.85% +155.28% +429.57 0 Comment
trackthinkequity 92.75 12/3/2010 Outperform NS $13.06 -17.38% +8.59% -25.97 2/15/2011 @ $10.79 0 Comment
TrackWedbush 88.31 12/7/2009 Outperform NS $9.76 +261.38% +165.11% +96.26 0 Comment
TrackBMOCapital < 20 9/23/2009 Outperform NS $10.15 +247.49% +173.80% +73.68 0 Comment
TrackBreanMurray 46.02 6/23/2009 Outperform NS $6.23 +466.13% +229.24% +236.89 0 Comment
TrackWMBlair 75.71 4/7/2009 Outperform NS $5.10 +591.57% +260.17% +331.40 0 Comment
TrackMorganJos 73.19 3/24/2009 Outperform NS $4.94 +613.97% +264.65% +349.32 0 Comment
TrackEveillard 93.69 9/30/2007 Outperform NS $8.83 -21.40% -13.94% -7.46 3/31/2008 @ $6.94 1 Comment
TrackSoros 84.48 9/30/2007 Outperform NS $8.83 -21.40% -13.94% -7.46 3/31/2008 @ $6.94 2 Comments
TrackOppenheimer 25.33 3/1/2007 Outperform NS $11.86 +197.39% +120.80% +76.59 0 Comment
TrackDeutscheSec 81.81 3/1/2007 Outperform NS $11.72 +200.94% +121.18% +79.76 0 Comment
TrackJimCramer 86.25 8/3/2006 Underperform 3W $16.54 +113.24% +145.06% +31.82 0 Comment
TrackJimCramer 86.25 6/21/2006 Outperform 3W $16.99 -2.65% +2.24% -4.89 8/3/2006 @ $16.54 0 Comment
TrackJimCramer 86.25 6/19/2006 Underperform 3W $17.42 -2.47% +0.97% +3.44 6/21/2006 @ $16.99 0 Comment
TrackJimCramer 86.25 4/27/2006 Outperform 3W $20.69 -15.80% -5.31% -10.49 6/19/2006 @ $17.42 0 Comment

Advertisement